Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine dose comparison with fentanyl for propofol requirements during painless gastroenteroscopy
ChiCTR1900028279Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of North Sichuan Medical College
- Start
- Dec 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine, fentanyl and propofol in None (5 arms), sponsored by Affiliated Hospital of North Sichuan Medical College. Primary endpoint: Body dynamic response. Planned start Dec 2019; status: not yet recruiting.
02
Drugs
dexmedetomidinefentanylpropofol
Beyond the preview
Go deeper on ChiCTR1900028279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900028279.